Screener
Krystal Biotech, Inc. KRYS Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except per share data) | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Other income | ||
| Interest and other income, net | 7,753 | 7,345 |
| Income before income taxes | 61,442 | 43,597 |
| Income tax expense | (5,510) | (7,864) |
| Net income | 55,932 | 35,733 |
| Unrealized (loss) gain on available-for-sale securities | (1,577) | 344 |
| Foreign currency translation | (1,182) | 236 |
| Comprehensive income | $53,173 | $36,313 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s income tax?
- Krystal Biotech, Inc. (KRYS) reported income tax of $5.51M in Q1 2026.
- How has Krystal Biotech, Inc.'s income tax changed year-over-year?
- Krystal Biotech, Inc.'s income tax decreased by 29.9% year-over-year, from $7.86M to $5.51M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Krystal Biotech, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude